nervous

The central nervous system (CNS), which is composed of the

brain and spinal cord, functions as the master control center

of the body. The brain has several main parts, including the

following:

• The cerebrum—the largest, upper part of the brain—controls voluntary muscles, perception, and what people commonly call “thinking.”

• The lower cerebellum controls many involuntary body

movements, such as swinging the arms while walking.

• The brain stem, which connects the brain to the spinal cord,

has a number of functions, including control of breathing,

heart rate, and blood pressure.

The spinal cord extends down from the brain stem only as far

as the lumbar region (lower back). Below this region, a bundle

of nerves called the cauda equina1 extends from the spinal cord.

As its name suggests, this bundle resembles the tail of a horse.

Bones of the cranium, bones of the vertebral column, and

three layers of tissue called meninges2 (mě-nin’jēz) surround the

brain and spinal cord, providing support and protection from

external shock. The three meninges vary in their structure and

appearance (FIGURE 20.1b, c).

Lying next to the bones is the dura mater3 (dŭ’ră mā’ter), a

tough fibrous sheath that provides a strong, yet flexible, covering for the soft organs of the CNS. It also provides a barrier

against the spread of infections from the bones. Deep to the

dura mater is the arachnoid mater4 (ă-rak’noyd mā’ter), which

contains numerous branching fibers giving the appearance of

a spider’s web. The cavities between the fibers of the arachnoid

mater are collectively called the subarachnoid space. The internal layer, which is pressed close to the spinal cord and brain, is

the pia mater5 (pī’ă mā’ter). Blood vessels on top of the pia mater

supply the CNS with blood. The walls of these blood vessels are

composed of tightly joined cells that form the blood-brain barrier, which prevents most microbes and large molecules in the blood

from entering the subarachnoid space. Thus, blood infections

do not easily spread to the CNS, but unfortunately, neither do

many common antimicrobial drugs, such as penicillin, cephalosporins, tetracyclines, and aminoglycosides, making it more

difficult to treat infections of the CNS.

Fluid leaks from the blood into the subarachnoid space

that lines the brain. This watery fluid—called cerebrospinal fluid

(CSF)—circulates throughout the subarachnoid space of both

brain and spinal cord to bathe both organs. Arachnoid villi or

arachnoid granulations, which are knoblike extensions of the

arachnoid mater, extend into a blood-filled cavity at the top of

the cranium and return CSF to the blood.

Cerebrospinal fluid acts as a shock absorber; provides

nutrients, electrolytes, and oxygen to the nervous tissues;

and removes wastes. In a medical procedure called a lumbar

puncture (spinal tap), physicians remove a sample of CSF from

the region of the subarachnoid space surrounding the cauda

equina. They insert a needle through the skin

between two of the lumbar vertebrae, through the dura mater

and subdural space, and through the arachnoid mater to reach

the CSF in the subarachnoid space.


y

The peripheral nervous system (PNS) is composed of nerves

that transfer commands from the CNS to muscles and glands

throughout the body and provide information to the CNS concerning events in the body. Cranial nerves extend from the brain

through holes in the cranial bones, and spinal nerves extend

from the spinal cord through gaps between vertebrae. Branches

of nerves often merge together to form a nerve plexus (see

Figure 20.1a).

Functionally, there are three types of nerves: Sensory nerves

primarily carry signals toward the CNS. The optic nerves from

the eyes are examples. Motor nerves carry signals from the CNS

to other organs of the body, and mixed nerves carry signals both

toward and away from the CNS.

Cells of the Nervous System

The entire nervous system is composed of two basic types of

cells—neurons and supportive cells called neuroglia. The smaller neuroglia provide a supportive scaffolding, insulation, and nutritive support and phagocytize

microbes. The cytoplasmic membrane of a neuron generates an

electrical signal called an action potential or nerve impulse.

The nucleus of a neuron lies in a region of cytoplasm called

the cell body. Outside the CNS, a collection of many neurons’ cell

bodies is called a ganglion. Two types of fingerlike cytoplasmic

processes extend from a cell body: numerous, perhaps hundreds,

of short dendrites and a longer single axon. Within the cytoplasm

of an axon, the cytoskeleton transports substances by a process

known as axonal transport. Do not confuse dendrites and axons,

which are part of individual cells (neurons), with sensory and

motor nerves, which are bundles of thousands of cells.


Bacterial meningitis involves inflammatory bacterial infection of

the meninges, commonly the pia mater and arachnoid mater

and, more rarely, the dura mater.

Signs and Symptoms

Bacterial meningitis is characterized by an increased number

of white blood cells in the CSF, sudden high fever, and intense

meningeal inflammation. The inflammation accounts for most

of the signs and symptoms: Swelling of the meninges retards

the normal flow of CSF, putting pressure on the underlying

organs. Inflammation of the cranial meninges typically produces severe headache, nausea, vomiting, pain, and in many

cases loss of various brain functions, leading to such conditions

as drowsiness, confusion, fretfulness, or irritability. Inflammation of the spinal meninges puts pressure on surrounding nerves and muscles, producing stiffness in the neck and

affecting sensory input and muscular control. When the brain

becomes infected—a condition called encephalitis—deafness,

blindness, drastic changes in the patient’s behavior, coma, or

death may result. Signs and symptoms of meningitis may rapidly develop; for example, meningococcal meningitis can kill

within six hours of the initial symptoms, allowing little time

for treatment.

A lumbar puncture reveals the normally clear CSF to be

milky in appearance because of the large number of bacteria and the increased number of white blood cells. Petechiae

(pe-tē’kē-ē)—small, dark purplish hemorrhages of blood vessels

in the skin—are sometimes present.

Pathogens and Virulence Factors

Researchers have shown that more than 50 species of bacteria

can cause meningitis. Among these are opportunistic members

of the normal microbiome, including species of Staphylococcus

(staf’i-1ō-kok’ŭs) and Streptococcus (strep-tō-kok’ŭs) as well as

Gram-negative enteric8 bacteria such as Escherichia coli (esh-ě-

rik’ē-ă ko’lī) and Klebsiella pneumoniae (kleb-sē-el’ă nū-mō’nē-ī).

However, five other species cause almost 90% of cases of bacterial meningitis. These are Neisseria meningitidis, Streptococcus

pneumoniae, Haemophilus influenzae, Listeria monocytogenes, and

Streptococcus agalactiae. All five of these bacteria have virulence

factors that allow them to resist phagocytosis and cause disease; the following sections detail these features.

Neisseria meningitidis Neisseria meningitidis (nī-se’rē-ă me-ninji’ti-dis) is one of only two species of Gram-negative cocci that

The terminal ends of axons have thousands of branches

that form junctions called synapses6 (sĭ-nap’sēz) with glands,

muscles, or other neurons. A synapse mediates transfer of a signal to a neighboring postsynaptic cell. In most synapses, there is

a synaptic cleft—an intercellular space about 40 nm wide

between the axon terminal and the postsynaptic cell. A synaptic cleft stops the transmission of electrical signals; therefore,

the signal between cells is chemical—an axon terminal releases

molecules called neurotransmitters into the synaptic cleft. A particular neurotransmitter may be stimulatory or inhibitory; that

is, it either (1) stimulates a muscle to contract, a gland to secrete,

or another neuron to carry a nerve impulse; or (2) inhibits such

activities.

Portals of Infection of the Central Nervous System

No openings allow microbial colonization of the central nervous

system; therefore, the CNS is an axenic (ā-zēn’ik) environment—

it has no normal microbiota. Pathogens may access the CNS

through breaks in the bones and meninges, through medical procedures such as spinal taps, or by traveling via axonal

transport in peripheral neurons to the CNS. Microbes carried

in the blood or lymph may penetrate the blood-brain barrier by

infecting and killing cells of the meninges, causing meningitis7

(men-in-jī’tis)—inflammation of the meninges. Some pathogens

gain access to the CNS when localized inflammation distorts

the cells of the blood-brain barrier, changing its permeability;

such change is more likely during chronic infection by many

pathogens. Circulation of cerebrospinal fluid can carry infective microbes throughout the cranial cavity and spinal column.

We will examine nervous system diseases caused by bacteria, viruses, fungi, protozoa, and prions. We begin by considering bacterial diseases.


Not only can bacteria infect cells of the nervous system, but

toxins released by bacteria growing elsewhere in the body can

also affect neurons. In the following sections, we consider disease examples of both types—leprosy, which is a disease of cells

found in the PNS, and botulism and tetanus, which involve

toxin production. However, the most common bacterial infection of the nervous system is bacterial meningitis, which we

consider next.

Bacterial meningitis involves inflammatory bacterial infection of

the meninges, commonly the pia mater and arachnoid mater

and, more rarely, the dura mater.

Signs and Symptoms

Bacterial meningitis is characterized by an increased number

of white blood cells in the CSF, sudden high fever, and intense

meningeal inflammation. The inflammation accounts for most

of the signs and symptoms: Swelling of the meninges retards

the normal flow of CSF, putting pressure on the underlying

organs. Inflammation of the cranial meninges typically produces severe headache, nausea, vomiting, pain, and in many

cases loss of various brain functions, leading to such conditions

as drowsiness, confusion, fretfulness, or irritability. Inflammation of the spinal meninges puts pressure on surrounding nerves and muscles, producing stiffness in the neck and

affecting sensory input and muscular control. When the brain

becomes infected—a condition called encephalitis—deafness,

blindness, drastic changes in the patient’s behavior, coma, or

death may result. Signs and symptoms of meningitis may rapidly develop; for example, meningococcal meningitis can kill

within six hours of the initial symptoms, allowing little time

for treatment.

A lumbar puncture reveals the normally clear CSF to be

milky in appearance because of the large number of bacteria and the increased number of white blood cells. Petechiae

(pe-tē’kē-ē)—small, dark purplish hemorrhages of blood vessels

in the skin—are sometimes present.

Pathogens and Virulence Factors

Researchers have shown that more than 50 species of bacteria

can cause meningitis. Among these are opportunistic members

of the normal microbiome, including species of Staphylococcus

(staf’i-1ō-kok’ŭs) and Streptococcus (strep-tō-kok’ŭs) as well as

Gram-negative enteric8 bacteria such as Escherichia coli (esh-ě-

rik’ē-ă ko’lī) and Klebsiella pneumoniae (kleb-sē-el’ă nū-mō’nē-ī).

However, five other species cause almost 90% of cases of bacterial meningitis. These are Neisseria meningitidis, Streptococcus

pneumoniae, Haemophilus influenzae, Listeria monocytogenes, and

Streptococcus agalactiae. All five of these bacteria have virulence

factors that allow them to resist phagocytosis and cause disease; the following sections detail these features.

Neisseria meningitidis Neisseria meningitidis (nī-se’rē-ă me-ninji’ti-dis) is one of only two species of Gram-negative cocci that regularly causes disease in humans. Researchers have identified

13 antigenic strains; strains A, B, C, and W135 cause most cases

of disease in humans. The cells of all strains of Neisseria are

nonmotile and are typically arranged as diplococci (pairs) with

their common sides flattened in a manner reminiscent of coffee

beans (FIGURE 20.2). The bacterium is known as the meningococcus and its disease as meningococcal meningitis.

Meningococci have fimbriae and polysaccharide capsules,

as well as a major cell wall antigen called lipooligosaccharide

(lĭp’ō-ŏl’ĭ-gō-sak’ă-rīd, LOS), composed of lipid A (endotoxin)

and sugar molecules—all of which enable the bacteria to

attach to human cells. Cells of Neisseria that lack any of these

three structural features are avirulent. The polysaccharide

capsules also resist lytic enzymes of the body’s phagocytes,

allowing phagocytized meningococci to survive, reproduce,

and be carried throughout the body within neutrophils and

macrophages.

Much of the damage caused by N. meningitidis results from

blebbing—a process in which the bacterium sheds extrusions

of its outer membrane. The lipid A component of LOS thereby

released into the body triggers fever, vasodilation, inflammation, shock, and widespread blood clotting.

Streptococcus pneumoniae Louis Pasteur discovered Streptococcus pneumoniae (strep-tō-kok’us nū-mō’nē-ī) in pneumonia

patients about 120 years ago. The bacterium is an encapsulated Gram-positive coccus, which forms short chains or, more

throat that opportunistically grow in the lungs, sinuses, and

middle ear and from those locations move into the meninges via

the blood. Streptococcus pneumoniae is a leading cause of meningitis in children less than 5 years old and in very old adults.

Even though microbiologists have studied pneumococci

extensively, they still do not fully understand how these bacteria cause disease; nevertheless, certain structural and chemical

virulence factors are necessary for disease.

The cells of all virulent strains of S. pneumoniae are surrounded by a polysaccharide capsule, which protects them

from digestion after phagocytosis. Unencapsulated strains

do not cause disease. Pathogenic pneumococci also produce

enzymes and toxins that enable the bacteria to counteract

immune defenses.

In addition, pathogenic S. pneumoniae possess a cell wall

chemical called phosphorylcholine, which is an adhesin that

binds to receptors on cells in the lungs, the meninges, and

blood vessel walls. Binding stimulates target cells to endocyrize the bacteria. Thus, the phosphorylcholine and polysaccharide capsule together enable pneumococci to “hide” inside

body cells. S. pneumoniae can then pass across these cells into

the blood and brain.

Haemophilus influenzae Haemophilus9 influenzae (hē-mof’i-lŭs

in-flu-en’zī) is a small pleomorphic bacillus (FIGURE 20.4)

that requires heme and NAD+ for growth. As a result, it is an

obligate parasite, colonizing mucous membranes of humans

and some animals. At one time—as the specific epithet indicates—scientists thought that the bacterium caused flu pandemics in 1890 and 1918, but H. influenzae causes meningitis,

not the flu. Most strains of H. influenzae have polysaccharide

capsules that resist phagocytosis. Researchers distinguish

among six strains of Haemophilus by differences in capsular antigens. Before the introduction of an effective vaccine in the

1990s, 95% of H. influenzae diseases in the United States were

caused by type b.

Listeria monocytogenes Listeria monocytogenes (lis-tēr’ē-ă mo-nō-

sī-to’je-nēz) is a Gram-positive, non-endospore-forming coccobacillus that enters the body in contaminated food or drink.

Listeria is rarely pathogenic in healthy adults; infection in pregnant women, fetuses, newborns, the elderly, and immunocompromised patients can result in meningitis.

Disease in Depth on pp. 602–603 examines listeriosis,

including meningitis caused by Listeria, in detail.

Streptococcus agalactiae Streptococcus agalactiae (strep-tō-kok’ŭs

a-ga-lak’tē-ī), also known as Lancefield10 group B Streptococcus

(based on its so-called B antigen), is a normal member of the

vaginal microbiota in about a third of all women. The bacterium

produces a protective capsule that allows it to evade phagocytosis when it gets into the blood. S. agalactiae also causes bacteremia, pneumonia, and meningitis in newborns.

Pathogenesis

Humans inhale N. meningitidis, H. influenzae, and S. pneumoniae

in respiratory droplets from infected individuals (who may

appear healthy). Babies pick up S. agalactiae during passage

through an infected birth canal. Listeria is transmitted in contaminated food, particularly meat and underpasteurized milk

and cheese.

In most cases, bacteria spread to the meninges from infections of the lungs, sinuses (sinusitis), or inner ear (otitis media)

via the blood (bacteremia). Head or neck surgery or trauma may

also open a passage into the subarachnoid space of the meninges. The bacteria, somewhat protected by their capsules from

phagocytosis, metabolize glucose in the CSF.

Epidemiology

Before the 1990s, H. influenzae was a leading cause of bacterial

meningitis. An effective childhood vaccine has reduced the

number of such cases by more than 90%. Today, S. pneumoniae (pneumococcus) and N. meningitidis (meningococcus) are more

prevalent causes of bacterial meningitis, though S. agalactiae is a

leading cause of bacterial meningitis in newborns in the United

States and the United Kingdom.

S. pneumoniae grows in the mouths and throats of 75% of

humans without causing harm; but in some patients, particularly children and the elderly—groups whose immune

responses are not fully active—these pneumococci become

bloodborne and invade the meninges.

None of the forms of bacterial meningitis are typically

spread by casual contact, though N. meningitidis can be spread

via respiratory droplets to other people who have prolonged

contact with a carrier. Meningoccoccal meningitis is the only

type of bacterial meningitis that becomes epidemic, particularly in sub-Saharan Africa, where massive epidemics occurred

every 5–12 years during the dry season (December to June). For

example, in the sub-Saharan nations in 2009, there were almost

90,000 cases. In 2014, as a result of mass immunization efforts

in 19 of the 26 African countries most at risk, there were only

11,908 cases.

In the United States, meningococcal meningitis is spread

among military personnel in barracks and students in dormitories. In fact, meningococcal disease is 9–23 times more

prevalent in students living in dormitories than in the general

population. Mortality of meningococcal meningitis approaches

100% in untreated patients, but is about 11% in patients who

have been treated appropriately with antimicrobial drugs.

Infant mortality from S. agalactiae meningitis has been

reduced to about 5% as a result of rapid diagnosis and supportive care, though about 25% of infants surviving this group B

streptococcal meningitis have permanent neurological damage,

including blindness, deafness, or severe mental retardation.

Listeria infects humans who consume contaminated food.

Human-to-human transmission of Listeria is limited to the transfer of bacteria from mother to fetus and can result in premature

delivery, miscarriage, stillbirth, or meningitis in the newborn.

Diagnosis, Treatment, and Prevention

Symptoms of meningitis should always be considered serious,

and a patient should consult a physician immediately. Quick

diagnosis is vital. Diagnosis of bacterial meningitis is based on

symptoms and culturing bacteria from CSF following a lumbar

puncture. Additionally, serological tests can demonstrate the

presence of antibodies against N. meningitidis, though strain

B of this species is relatively nonimmunogenic and therefore

often not revealed by such tests.

Physicians treat bacterial meningitis with any of a number

of intravenously administered antimicrobial drugs, typically

vancomycin plus ceftriaxone, cefotaxime, meropenem, or ampicillin, depending on the age and health of the patient and the

bacterium causing the meningitis. Quick treatment reduces the

mortality to below 15% of cases of bacterial meningitis.

Prevention of bacterial meningitis depends on interrupting

the transmission of pathogens and their spread in the body. The

U.S. Centers for Disease Control and Prevention (CDC) recommends vaccination of children against Streptococcus pneumoniae,

Haemophilus influenzae type B (Hib), and Neisseria meningitidis

(see Chapter 17, Figure 17.3) and administration of penicillin

at birth to any child whose mother’s vagina is colonized with

Streptococcus agalactiae (group B Streptococcus). Implementation

of the latter recommendation in 1996 reduced neonatal meningitis by 70% within five years. Additionally, health care providers

prevent the spread of group B streptococcal infection to babies

by treating infected pregnant mothers with penicillin or ampicillin, or with vancomycin for patients with penicillin allergy.

The CDC also recommends meningococcal vaccination for

all military recruits and college freshmen. Health care providers administer antimicrobials such as cirpofloxacin, ceftriaxone,

or rifampin to people in prolonged contact with meningococcal

patients. Such prophylactic treatment is not recommended following exposure to meningitis caused by other microbes.

Coxsackie, New York, where the virus was first isolated), coxsackie B virus, and echovirus.

16 (Other viruses, called arboviruses,

may also affect the meninges, but their primary target is nerve

cells. These viruses are considered in a later section.)

Pathogenesis

Enteroviruses primarily attack cells lining the intestinal tract

and lungs, in the latter case producing colds. The viruses are

cytolytic—they kill their target cells. Damage to cells in the

meninges triggers meningitis.

The incubation period of enterovirus infections is between

three and seven days, and patients recover completely without

treatment after another seven to ten days.

Epidemiology

Viral meningitis appears to be much more common than bacterial or fungal meningitis, but viral meningitis is often mild, and

the disease is not reportable, so firm data are not available.

Enteroviruses are contagious, being spread in respiratory

droplets and in feces—patients shed viruses in their feces for

weeks. For some reason, enteroviruses are more commonly

spread in the summer and early fall. The viruses are stable and

can survive in chlorinated swimming pools.

Exposure to a patient with meningitis may result in an

infection resembling a cold but rarely causes meningitis—fewer

than one of every 1000 infected people develop viral meningitis. Patients become contagious when symptoms develop and

remain contagious for up to 10 days.

Diagnosis, Treatment, and Prevention

Physicians diagnose viral meningitis based on the characteristic signs and symptoms in the absence of bacteria in CSF

obtained with a spinal tap.

No specific treatment exists for viral meningitis; health

care providers recommend resting, drinking plenty of fluids,

and taking medicine to reduce fever and headache pain.

It is difficult to suppress the spread of enteroviruses

because most infected people lack signs or symptoms. Frequent

hand antisepsis, avoiding crowded swimming pools, and

refraining from bringing contaminated hands near the mouth,

nose, or eyes limit the chance of infection.




Viral Diseases of the Nervous System

Viruses, being smaller than cells, can more readily cross the

blood-brain barrier; therefore, it is not surprising that there

are more viral infections of the nervous system than bacterial

or fungal infections. Many viruses that attack other body systems can also affect the brain: herpes and chickenpox viruses

may remain dormant in nerve cells for years, and measles virus

causes subacute sclerosing panencephalitis, which is a slow progressive's disease of the CNS. (Chapter 19 dealt with these pathogens, which primarily affect the skin.)

In the following sections we consider viruses that primarily

affect the nervous system, causing meningitis, polio, rabies, and

encephalitis. We begin our survey by considering viral meningitis.


Viral Meningitis

Signs and Symptoms

Viral meningitis is usually a milder disease than either bacterial

or fungal meningitis; although the signs and symptoms—fever,

severe headache, stiff neck, drowsiness, confusion, nausea, and

vomiting—may be the same, death from viral meningitis is rare.

Some meningitis viruses also cause skin rashes, sore throats,

and colds.

Pathogens and Virulence Factors

Herpesviruses, mumps virus, and several other viruses may

cause viral meningitis, but about 90% of cases result from infections of viruses in the genus Enterovirus14 of the family Picornaviridae.

15 As their name indicates, picornaviruses are very small

(20–30 nm in diameter), positive, single-stranded RNA

(+ssRNA) viruses. They lack envelopes. Enteroviruses are so

named because they often spread from person to person via

fecal contamination of food, water, or hands. Though ingested

enteroviruses attack cells lining the intestinal tract, they do not

cause gastrointestinal illnesses; instead, enteroviruses spread

via the bloodstream—a condition called viremia—to infect

other organs, including the meninges.

The common names for the three types of enterovirus that

cause most human meningitis are coxsackie A virus (named for Coxsackie, New York, where the virus was first isolated), coxsackie B virus, and echovirus.

16 (Other viruses, called arboviruses,

may also affect the meninges, but their primary target is nerve

cells. These viruses are considered in a later section.)

Pathogenesis

Enteroviruses primarily attack cells lining the intestinal tract

and lungs, in the latter case producing colds. The viruses are

cytolytic—they kill their target cells. Damage to cells in the

meninges triggers meningitis.

The incubation period of enterovirus infections is between

three and seven days, and patients recover completely without

treatment after another seven to ten days.

Epidemiology

Viral meningitis appears to be much more common than bacterial or fungal meningitis, but viral meningitis is often mild, and

the disease is not reportable, so firm data are not available.

Enteroviruses are contagious, being spread in respiratory

droplets and in feces—patients shed viruses in their feces for

weeks. For some reason, enteroviruses are more commonly

spread in the summer and early fall. The viruses are stable and

can survive in chlorinated swimming pools.

Exposure to a patient with meningitis may result in an

infection resembling a cold but rarely causes meningitis—fewer

than one of every 1000 infected people develop viral meningitis. Patients become contagious when symptoms develop and

remain contagious for up to 10 days.

Diagnosis, Treatment, and Prevention

Physicians diagnose viral meningitis based on the characteristic signs and symptoms in the absence of bacteria in CSF

obtained with a spinal tap.

No specific treatment exists for viral meningitis; health

care providers recommend resting, drinking plenty of fluids,

and taking medicine to reduce fever and headache pain.

It is difficult to suppress the spread of enteroviruses

because most infected people lack signs or symptoms. Frequent

hand antisepsis, avoiding crowded swimming pools, and

refraining from bringing contaminated hands near the mouth,

nose, or eyes limit the chance of infection.


poliomyelitis


Signs and Symptoms

After being ingested and infecting pharyngeal and intestinal

cells, poliovirus travels via the lymph and blood to infect cells

of the CNS, particularly of the spinal cord. It causes one of the

following four conditions:

• Asymptomatic infections account for about 90% of all cases.

• Minor polio includes nonspecific symptoms such as temporary fever, headache, malaise, and sore throat. Approximately 5% of cases are minor polio. • Nonparalytic polio results from polioviruses invading the

meninges and central nervous system, producing muscle

spasms and back pain in addition to the general symptoms of

minor polio. Nonparalytic polio occurs in about 2% of cases.

• Paralytic polio involves viral invasion of cells of the spinal

cord and the portion of the cerebrum that controls skeletal

muscles, producing paralysis by limiting nerve impulse

conduction. The degree of paralysis varies with the strain

of poliovirus involved, the infective dose, and the health

and age of the patient. In a type of paralytic polio called

bulbar poliomyelitis, the brain stem is infected, resulting in

paralysis of respiratory muscles or of muscles in the limbs

(see Disease at a Glance 20.3). In the past, iron lungs were

used to help victims breathe. In most paralytic cases, complete recovery results after 6–24 months, but in some cases

paralysis is lifelong. Paralytic polio occurs in fewer than

2% of infections.

Postpolio syndrome is a crippling deterioration in the function of polio-affected muscles that occurs in up to 80% of recovered polio patients some 30–40 years after their original bout

with poliomyelitis. This condition is not caused by a reemergence of polioviruses, because viruses are not present. Instead,

the effects appear to stem from an aging-related aggravation of

nerve damage that occurred during the original infection.

Pathogen and Pathogenesis

Poliovirus is another species of Enterovirus (family Picornaviridae). Poliovirus is relatively stable outside the body and remains

infectious in food and water for some time. Scientists distinguish three strains of poliovirus by their antigens. Each of the

three can cause all types of polio.

People most often get poliovirus by drinking contaminated

water. The viruses are replicated in cells of the throat and small

intestine, producing initial symptoms of sore throat and nausea. Viruses then infect lymph nodes and from there enter the

blood. In most people, the infection ends there; however, viremia may progress to infection of neurons of the CNS. Paralysis develops following destruction of motor neurons in the upper

spinal cord and brain stem; poliovirus does not infect muscles.

Epidemiology

The near elimination of polio stands as one of the great achievements of 20th-century medicine. Soon, like smallpox virus,

poliovirus will exist only in laboratories.

The last case of naturally occurring poliomyelitis in

the Americas occurred in 1979. A milestone was reached in

2014 when the World Health Organization (WHO) declared

Southeast Asia, including India, polio free. Worldwide, the number of naturally acquired polio cases dropped from 350,000 in

1988 to a low of only 74 in 2015. Additionally, there were 32 cases

of vaccine-derived polio. Polio currently exists endemically only

in Pakistan and Nigeria, though there was a quickly contained

reemergence in Nigeria in 2016 (see Figure 20.10).

Diagnosis, Treatment, and Prevention

Diagnosis of polio is based upon demonstration of the virus

in throat secretions or feces. There is no specific treatment for

polio besides managing the symptoms of infection.

Two effective vaccines make polio eradication possible.

Jonas Salk (1914–1995) developed an inactivated polio vaccine

(IPV) in 1955. Later, it was replaced by a live, attenuated (weakened), oral polio vaccine (OPV) developed by Albert Sabin

(1906–1993). Both vaccines are effective in providing immunity

against all three strains of poliovirus. Healthcare workers have

returned to using IPV because the attenuated viruses in OPV

occasionally mutate into virulent viruses that cause cases of

vaccine-derived polio. TABLE 20.1 compares the advantages

and disadvantages of the two vaccines.

Disease at a Glance 20.3 summarizes the characteristics of

polio.

rabies
Signs and Symptoms

Initial signs and symptoms of rabies include pain or itching at

the site of infection, fever, headache, malaise, and anorexia.

Once the virus reaches the central nervous system, neurological manifestations characteristic of rabies develop: hydrophobia18 (triggered by the pain involved in attempts to swallow

water), seizures, disorientation, hallucinations, and paralysis.

Death results from respiratory paralysis and other neurological

complications.

Pathogen and Virulence Factors

Rabies virus is a negative, single-stranded RNA (@ssRNA)

virus in the genus Lyssavirus, family Rhabdoviridae.

Rhabdoviruses have helical capsids supercoiled into cylinders,

which give them a striated appearance, and are surrounded

by bullet-shaped envelopes (see Disease at a Glance 20.4).

Glycoprotein spikes on the surface of the envelope serve as

attachment proteins.

Pathogenesis

Rabies virus attaches to skeletal muscle cells, triggering its own

endocytosis. The virus replicates in the cytoplasm of muscle

cells. Later, it moves across neuromuscular junctions into neurons and then travels to the central nervous system via axonal

transport.

Function of the spinal cord and brain degenerate as a result

of infection, though infected cells show little structural damage when examined microscopically. Viruses travel back to

the periphery, including the salivary glands, through cranial

and spinal nerve cells. Viruses are secreted in the saliva of

infected mammals. Transmission of rabies viruses in the saliva

of infected animals usually occurs via a bite but can occur

through the introduction of viruses into breaks in the skin or

mucous membranes or, rarely, through inhalation.

Epidemiology

Rabies is a zoonosis, that is, a disease spread from animal reservoirs to humans. Rabies affects mammals, though not all

mammals are reservoirs; rodents, for instance, rarely get rabies.

The main mammals involved differ from locale to locale and

change over time as a result of changes in animal populations

and interactions among animals and humans. The primary reservoir of rabies in urban areas is the dog. In the wild, rabies

can be found in many animals, including foxes, badgers, raccoons, skunks, cats, bats, and feral dogs (FIGURE 20.11). Bats

are the source of most cases of rabies in humans, causing about

75% of cases. Only one case of rabies in humans occurred in the

United States in 2015.

Diagnosis, Treatment, and Prevention

The neurological symptoms of rabies are unique and generally

sufficient for diagnosis. Tests for antibodies in the blood confirm the diagnosis. Postmortem laboratory tests are often conducted to determine whether a suspected animal in fact carries

rabies virus. These tests include antigen detection by immunofluorescence and the identification of aggregates of viruses

(called Negri bodies) in the brain (FIGURE 20.12). Unfortunately, by the time symptoms appear and antibody production

occurs, it is too late to intervene, and the disease will follow its

natural course.

Human rabies vaccine, which is called human diploid cell

vaccine (HDCV), is prepared from deactivated rabies viruses

cultured in human diploid cells. It is administered intramuscularly on days 0, 3, 7, and 14 after exposure to rabies virus. The

vaccine can also be administered before infection to workers

who regularly come into contact with animals (veterinarians, zookeepers, and animal control workers) and to people traveling to areas of the world where rabies is prevalent.

Treatment of rabies begins with treatment of the site of

infection. The wound should be thoroughly cleansed with

water and soap or another substance that deactivates viruses.

The World Health Organization recommends anointing the

wound with antirabies serum. Initial treatment also involves

injection of human rabies immunoglobulin (HRIG). Subsequent

treatment involves the four vaccine (HDCV) injections, mentioned previously. Rabies is one of the few infections that

can be treated with active immunization because the progress

of viral replication and movement to the brain is slow enough

to allow effective immunity to develop before disease develops.

The control of rabies involves immunization of domestic

dogs and cats and the removal of unwanted strays from urban

areas. It is more difficult to eliminate rabies in wild animals

because rabies virus can infect so many species, though in the

late 1990s an epidemic of rabies was stopped in southern Texas

by the successful immunization of the wild coyote population.

This was accomplished by lacing meat with an oral vaccine and

dropping it from airplanes into the coyotes’ range.


arboviral encephalitis
Signs and Symptoms

Most mosquito-borne arboviruses cause only mild, coldlike

symptoms in humans within three to seven days of infection.

Occasionally arboviruses in the blood cross the blood-brain

barrier to cause arboviral encephalitis, which is characterized by signs and symptoms similar to those of meningitis:

high fever, weakness, nausea, vomiting, abrupt headache, and

changes in mental state such as confusion, disorientation, and

coma. Some patients report body aches and develop a skin rash.

Neurological effects may be permanent.

Humans are not the only victims. Arboviruses also attack

birds, horses, chimpanzees, cats, dogs, chipmunks, and even

alligators. (Scientists are not sure how thick-skinned gators contract the disease.)

Pathogens

Six arboviruses cause most cases of viral encephalitis in Americans. Scientists name these viruses for the geographic regions

where the diseases or viruses were first identified. The diseases

and their viruses are:

• Eastern equine encephalitis (EEE), Western equine encephalitis (WEE), and Venezuelan equine encephalitis (VEE), all

of which were first identified in horses in the eastern United

States, western United States, and Venezuela, respectively.

The viruses causing these conditions are all enveloped,

+ssRNA viruses in the family Togaviridae (FIGURE 20.13).

• St. Louis encephalitis and West Nile encephalitis, which

were first identified in St. Louis, Missouri, and West Nile

Province, Uganda (Africa), respectively. Their enveloped,

+ssRNA viruses are in the family Flaviviridae; they differ

from togaviruses in their antigens. West Nile virus (WNV),

which arrived in the United States in 1999, has had the

most impact on people in the United States.

• California (also known as LaCrosse) encephalitis, which

is endemic to California but was first described from

LaCrosse, Wisconsin. The virus, which is enveloped and has

a segmented @ssRNA genome, is in the family Bunyaviridae.

Physicians are concerned that new forms of viral encephalitis

have appeared in Asia and Australia.

Pathogenesis

female Aedes or Culex mosquitoes carry the viruses among infected hosts. Mosquitoes remain

infected with arboviruses, which they pass to their offspring in eggs; mothers and their female young are a continual source of

new infections. Viruses overwinter in eggs or hibernating mosquitoes. Researchers have demonstrated that West Nile virus

and other arboviruses can be transmitted between people via

blood transfusion and transplanted organs.

Arboviruses enter target cells via endocytosis and replicate

within them. They produce viremia and can cross the bloodbrain barrier by an unknown mechanism to cause encephalitis.

In horses and humans, viruses are released from infected cells

into the blood (viremia), but the concentration of viruses in

their blood is never high enough to infect mosquitoes, so horses

and humans are “dead-end” hosts for arboviruses.

Most patients experience severe flulike symptoms but survive, though 50% of patients still suffer a year later with headaches, cognitive and memory impairment, fatigue, tremors, or

depression. Mortality ranges from less than 1% with California

encephalitis to 35% with EEE, which is the most severe arboviral encephalitis in people.

Epidemiology

The normal host for encephalitis arboviruses is either a bird

(viruses of EEE, WEE, St. Louis encephalitis, and West Nile

encephalitis) or a rodent (viruses of VEE and California encephalitis). People who engage in work or recreation outdoors in

endemic areas are at risk of accidental infection, and those

older than 50 are at a higher risk of contracting EEE, St. Louis

encephalitis, and West Nile encephalitis. Children are at higher

risk for WEE, VEE, and California encephalitis.

As their names suggest, EEE, WEE, and VEE are typically

limited to the eastern United States, western United States, and

South and Central America, respectively. California encephalitis has been reported in most states west of the Mississippi

River; St. Louis and West Nile viral infections occur in the

lower continental 48 states.

The incidence of all types of arboviral encephalitis in the

United States is seasonal, with peaks that correspond to the

times of the year during which adult mosquitoes are active.

For example, FIGURE 20.15 illustrates the seasonal nature of

reported cases of encephalitis caused by West Nile virus. Birds

spread many types of arboviruses rapidly through an environment. This was dramatically demonstrated by the spread of

West Nile virus from New York City in 1999 across the continent

in just four years. Species of Culex mosquito and 300 species of

birds transmit and harbor WNV. House sparrows are an important bird reservoir—they don’t die when infected, and their huge

population means they outnumber all other bird carriers.

TABLE 20.2 (p. 617) summarizes the distribution, vectors,

hosts, and epidemiology of arboviral encephalitis in the United

States.

Diagnosis, Treatment, and Prevention

Diagnosis of human arboviral encephalitis is based upon observation of signs and symptoms followed by a positive laboratory

test for antibodies against specific arboviruses in the CSF. A commonly used laboratory test measures the concentration of IgM, the

antibody class produced early in an infection. The test is positive

in most infected people within eight days of onset of symptoms. As with viral meningitis, treatment for arboviral encephalitis

is supportive: possible hospitalization, administration of intravenous fluids, respiratory support (ventilator), prevention of secondary infections—in other words, good nursing care. Such treatment

for a prolonged, serious case of WEE can cost nearly $3 million!

Human disease is prevented by limiting contact with

mosquitoes—through the use of netting and insect repellent containing DEET (N,N-diethyl-m-toluamide)—and by reducing mosquito numbers through the elimination of stagnant water, which

is a common breeding site for Culex, and the use of insecticides.

Veterinarians can administer effective vaccines against

EEE, WEE, VEE, and WNV to horses, but the U.S. Food and

Drug Administration (FDA) has not approved human vaccines.

Scientists have developed an effective human vaccine against

West Nile virus; safety trials are ongoing.


cryptococcal meningitis
Cryptococcal meningitis (cryptococcosis) affects people worldwide. Unlike other forms of fungal meningitis, it affects healthy

people as well as those who are sick or immunocompromised.

Signs and Symptoms

Cryptococcal meningitis manifests with signs and symptoms

common to bacterial meningitis: headache, dizziness, drowsiness, irritability, confusion, nausea, vomiting, and neck stiffness. In late stages of the disease, loss of vision and coma occur.

Acute onset of rapidly fatal cryptococcal meningitis occurs in

individuals with widespread infection. Pathogen and Virulence Factors

Cryptococcus neoformans is a basidiomycete yeast; that is, it is a

spherical, single-celled fungus that reproduces sexually with

basidiospores. It lives in soil, the feces of birds, and the sap of

eucalyptus trees.

Scientists recognize two variants of the yeast, both of which

are found worldwide. C. neoformans var. gattii primarily infects

immunocompetent individuals, whereas C. neoformans var. neoformans predominantly infects immunocompromised hosts.

Approximately 50% of all cryptococcal infections reported each

year are due to the latter variant.

The polysaccharide capsule that surrounds each cryptococcal cell is resistant to phagocytosis by defensive cells of the

body. The pathogenesis of Cryptococcus is also enhanced by

the ability of the yeast to produce melanin, which appears to

inhibit phagocytic killing mechanisms. The yeast has a predilection for the central nervous system.

Pathogenesis and Epidemiology

Human infections begin in the lungs following inhalation of

spores and/or dried yeast cells made airborne when bird droppings containing the fungus are disturbed by the activities of

the birds or humans. People who work around buildings where

birds roost are at increased risk of infection. In most individuals, phagocytes in the lungs limit spread of the yeast, but in

some patients, the fungus spreads via the blood throughout the

body. It infects both meninges and brain tissue.

Before the advent of AIDS, there were fewer than 500 infections annually worldwide. Now, terminal AIDS patients (who

have little immune function remaining) account for almost a

million cryptococcal infections each year globally, and about

625,000 die.

Diagnosis, Treatment, and Prevention

The preferred method of confirming cryptococcal meningitis is

detection of fungal antigen in CSF. In AIDS patients, antigen

can be detected in serum as well. Fungal stains revealing the

presence of encapsulated yeast in CSF are highly suggestive

of cryptococcal meningitis, even if no obvious symptoms are

present.

Treatment is with intravenous amphotericin B and oral

5-fluorocytosine administered together for at least four weeks.

The two drugs enhance one another, allowing lower doses of

amphotericin B, which is toxic to humans, to be used; however,

toxicity is not eliminated. Though AIDS patients may appear

well following primary treatment, the fungus typically remains

and must be actively suppressed by lifelong oral fluconazole

treatment.

Because the fungus is a threat to sick individuals, facilities

such as hospitals and nursing homes often place devices that

deter the roosting of birds near outside air-intake vents in an

effort to prevent Cryptococcus-contaminated air from entering

the building. No vaccine against Cryptococcus is available.

Disease at a Glance 20.6 summarizes the features of cryptococcal infection.

Having examined bacterial, viral, and fungal neurological

diseases, we turn our attention to representative diseases of the

nervous system caused by protozoa.


variant creutz-jakob disease

Signs and Symptoms

In vCJD, brain tissue is destroyed, and numerous cavities form

(see Disease at a Glance 20.7 on p. 623). As the brain deteriorates, victims experience insomnia, weight loss, and memory

failure. They also act irrationally, lose control of their muscles, and are unable to speak, walk, or maintain posture. Muscle

spasms progressively worsen as the disease progresses. Death

usually occurs within 12 months.

Pathogen, Pathogenesis, and Epidemiology

A prion protein causes vCJD. Prions exist in one of two

three-dimensional forms (see Figure 13.22): The normal form

is anchored in lipid rafts in membranes of neurons of the CNS

and is necessary for normal brain function, though scientists

don’t understand its exact role. An abnormal prion acts as an

enzyme to refold the normal form into a copy of the abnormal

form. Newly misfolded prions then proceed to make copies of

themselves from surrounding normal prion molecules. In other

words, abnormal prions turn normal prion proteins into abnormal prions, which continue the process. The disease progresses

unrelentingly, destroying the brain as it does.


Medical procedures such as transplants, blood transfusion

from an infected person, use of contaminated surgical instruments, and injection of growth hormones derived from infected

pituitary glands can spread the disease. Prions may remain

dormant for more than 60 years.

Unlike the genetic form of CJD, variant CJD strikes even

young people who consume contaminated nerve tissue, typically in meat products such as sausages. Since its discovery in

1996, vCJD has killed about 225 people. Studies suggest that 1 in

2000 people in the United Kingdom are infected with the abnormal prion; thousands of British people wonder whether they

have been infected and will succumb to vCJD in the future.

Diagnosis, Treatment, and Prevention

The characteristic signs and symptoms of vCJD are diagnostic

in the young but can be confused with other forms of dementia

in the elderly. Laboratory tests on samples from the CNS confirm the presence of abnormal prion in the brain.

No treatment is available for vCJD, though interleukins

may slow disease progression. It is difficult to destroy prions

even outside the body—prions survive cooking, freezing, pickling, and even normal autoclaving. Currently, autoclaving in a

concentrated solution of sodium hydroxide is recommended to

destroy prions, but you would not want to eat a hot dog prepared that way! The European Union but not the United States

has approved an enzyme treatment to remove prions from the

environment.

Prevention of vCJD is possible only by remaining free of

the prion by avoiding contaminated meat, particularly meat

cut from bones near the spinal cord and processed meats made

from brains or spinal cords of infected animals. As British

farmers and ranchers learned, destruction of potentially

infected sheep and cattle herds is mandatory to prevent the

spread of vCJD. Further, governments have initiated strict laws

and inspection procedures to prevent the use of contaminated

animal protein in food supplements for herbivores.

Disease at a Glance 20.7 summarizes the features of variant Creutzfeldt-Jakob disease.